Streetbeat News

Analyst Ratings

WWD

TD Cowen has downgraded Woodward (NASDAQ:WWD) from Buy to Hold and reduced the price target from $186 to $160, indicating a less optimistic outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 10:43 am

SMMT

HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Buy rating for Summit Therapeutics (NASDAQ:SMMT) and maintained a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 10:30 am

ETON

HC Wainwright & Co. has maintained a Buy rating on Eton Pharmaceuticals and raised the price target from $9 to $11, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 10:28 am

HALO

HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Buy rating for Halozyme Therapeutics, maintaining a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 10:25 am

JAMF

Needham analyst Joshua Reilly has reiterated a Buy rating on Jamf Holding (NASDAQ:JAMF) and maintained a price target of $25.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 10:16 am

LEGN

HC Wainwright & Co. has reiterated its Buy rating on Legend Biotech, maintaining a price target of $73. This suggests confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 10:12 am

MTB

Wolfe Research has upgraded M&T Bank (NYSE:MTB) from Peer Perform to Outperform, setting a price target of $210.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 10:08 am

STLA

RBC Capital has downgraded Stellantis from Outperform to Sector Perform, indicating a less favorable outlook for the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 10:05 am

LI

Macquarie analyst Eugene Hsiao has downgraded Li Auto from Outperform to Neutral, while raising the price target from $25 to $33.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 10:00 am